Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Left ventricular hypertrophy: virtuous intentions, malign consequences.

Saraswati Pokharel1, Umesh C Sharma, Yigal M Pinto

  • 1Department of Cardiology, University of Maastricht, P. Debyelaan 25, 6202 AZ Maastricht, The Netherlands.

The International Journal of Biochemistry & Cell Biology
|April 5, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Laminopathies: natural history and risk prediction of heart failure.

European heart journal·2026
Same author

Impact of TP53, KEAP1 and STK11 mutations in localized-stage NSCLC: A European thoracic oncology platform lungscape project.

European journal of cancer (Oxford, England : 1990)·2026
Same author

NCCN Guidelines® Insights: Small Cell Lung Cancer, Version 2.2026.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
Same author

Top stories on cardiac gene therapy delivery.

Heart rhythm·2026
Same author

Macrophage surface protein Mac-2 mediates inflammatory and stromal stress pathways in doxorubicin-induced cardiac injury.

Cardio-oncology (London, England)·2026
Same author

Corrigendum: Patient-specific 3D-printed coronary models based on coronary computed tomography angiography volumes to investigate flow conditions in coronary artery disease (2020<i>Biomedical Physics & Engineering Express</i><b>6</b>045007).

Biomedical physics & engineering express·2026
Same journal

Corrigendum to "Sodium butyrate down-regulation of indoleamine 2, 3-dioxygenase at the transcriptional and post-transcriptional levels" [Int. J. Biochem. Cell Biol. 42 (2010) 1840-1846].

The international journal of biochemistry & cell biology·2026
Same journal

Whole-brain spatial metabolomics reveals metabolic gradient shifts in a murine glioma model following boron neutron capture therapy (130 characters).

The international journal of biochemistry & cell biology·2026
Same journal

LCN2 modulates Th17/Treg balance in vitro and is associated with an adaptive response to intestinal ischemia-reperfusion injury under Hmox1-deficient conditions.

The international journal of biochemistry & cell biology·2026
Same journal

Chloroquine modulates the redox-sensitive signalling via inhibiting the AMPK-ULK1 under LPS induced state in murine splenic macrophages.

The international journal of biochemistry & cell biology·2026
Same journal

The vicious cycle of hyperglycemia and oxidative stress: Novel mechanistic insights into a pathogenic alliance.

The international journal of biochemistry & cell biology·2026
Same journal

Fibroblast growth factors (FGF) in the pathogenesis and treatment of inflammatory bowel diseases (IBD): An overview.

The international journal of biochemistry & cell biology·2026
See all related articles

Left ventricular hypertrophy (LVH) involves complex changes in heart structure and function, leading to heart failure. Targeting neuroendocrine activation offers a promising therapeutic strategy for managing LVH progression and improving patient outcomes.

Area of Science:

  • Cardiovascular Research
  • Cardiac Pathophysiology
  • Molecular Cardiology

Background:

  • Left ventricular hypertrophy (LVH) is a significant cardiovascular condition characterized by complex pathophysiology.
  • LVH involves myofilament structural changes, cytoskeletal disorganization, and increased collagen synthesis, contributing to cardiac remodeling and heart failure.
  • Current research emphasizes the role of neuroendocrine activation in LVH progression.

Purpose of the Study:

  • To explore the complex pathophysiology of left ventricular hypertrophy.
  • To evaluate the effectiveness of novel treatment strategies targeting neuroendocrine activation in LVH.
  • To understand the fundamental biology of LVH through treatment evolution.

Main Methods:

  • Review of current cardiovascular research on LVH.

Related Experiment Videos

  • Analysis of signal transduction pathways and calcium homeostasis in LVH.
  • Examination of structural changes including myofilaments, cytoskeleton, and collagen synthesis.

    • Main Results:

    • LVH is associated with progressive left ventricular remodeling and culminates in heart failure.
    • Inhibition of neurohormones is hypothesized to provide long-term benefits in morbidity and mortality for LVH patients.
    • Conventional treatments like diuretics and vasodilators show limited efficacy in reducing LV mass and improving prognosis.

    Conclusions:

    • The pathophysiology of LVH is intricate, involving molecular and structural alterations.
    • Therapeutic strategies targeting neuroendocrine pathways represent a promising approach for LVH management.
    • Understanding the biology of LVH through treatment advancements is crucial for improving patient outcomes.